Eli Lilly shares surge on a beat-and-raise, proving the stock's swoon was a mistake
CNBC
—
Eli Lilly entered Thursday well off its highs.
A blowout quarter shows the market got this one wrong.
GLP-1 drugs treat alcohol addiction
- Active ingredient in Ozempic shows early promise for treating alcohol use disorder ABC News —
- US prescription spending could top $1 trillion. GLP-1s lead the way USA Today —
- People with alcohol problems could benefit from taking weight loss jabs, researchers find The Independent —
- Weight loss jabs could benefit those with alcohol problems, experts reveal LBC —
- Health Care Roundup: Market Talk Wall Street Journal —